Literature DB >> 4028848

Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures.

S M Brooks, M A Weiss, I L Bernstein.   

Abstract

Ten individuals developed an asthma-like illness after a single exposure to high levels of an irritating vapor, fume, or smoke. In most instances, the high level exposure was the result of an accident occurring in the workplace or a situation where there was poor ventilation and limited air exchange in the area. In all cases, symptoms developed within a few hours and often minutes after exposure. We have designated the illness as reactive airway dysfunction syndrome (RADS) because a consistent physiologic accompaniment was airways hyperreactivity. When tested, all subjects showed positive methacholine challenge tests. No documented preexisting respiratory illness was identified nor did subjects relate past respiratory complaints. In two subjects, atopy was documented, but in all others, no evidence of allergy was identified. In the majority of the cases, there was persistence of respiratory symptoms and continuation of airways hyperreactivity for more than one year and often several years after the incident. The incriminated etiologic agent varied, but all shared a common characteristic of being irritant in nature. In two cases, bronchial biopsy specimens were available, and an airways inflammatory response was noted. This investigation suggests acute high level, uncontrolled irritant exposures may cause an asthma-like syndrome in some individuals which is different from typical occupational asthma. It can lead to long-term sequelae and chronic airways disease. Nonimmunologic mechanisms seem operative in the pathogenesis of this syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028848     DOI: 10.1378/chest.88.3.376

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  118 in total

1.  Short term respiratory effects of acute exposure to chlorine due to a swimming pool accident.

Authors:  N Agabiti; C Ancona; F Forastiere; A Di Napoli; E Lo Presti; G M Corbo; F D'Orsi; C A Perucci
Journal:  Occup Environ Med       Date:  2001-06       Impact factor: 4.402

2.  Abnormal epithelial structure and chronic lung inflammation after repair of chlorine-induced airway injury.

Authors:  Yiqun Mo; Jing Chen; David M Humphrey; Ramy A Fodah; Jonathan M Warawa; Gary W Hoyle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

3.  Reactive airway dysfunction syndrome in Ireland.

Authors:  A M McLaughlin; E M C Kone; M X Fitzgerald
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

4.  Non-sensitising air pollution at workplaces and adult onset asthma.

Authors:  U Flodin; P Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2003-09-23       Impact factor: 3.015

5.  Preventing occupational asthma.

Authors:  K M Venables
Journal:  Br J Ind Med       Date:  1992-12

Review 6.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

7.  Emerging exposures and respiratory health: World Trade Center dust.

Authors:  William N Rom; Joan Reibman; Linda Rogers; Michael D Weiden; Beno Oppenheimer; Kenneth Berger; Roberta Goldring; Denise Harrison; David Prezant
Journal:  Proc Am Thorac Soc       Date:  2010-05

Review 8.  Sensory detection and responses to toxic gases: mechanisms, health effects, and countermeasures.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Proc Am Thorac Soc       Date:  2010-07

9.  Prolonged hypoxaemia following inhalation of hydrogen chloride vapour.

Authors:  M J Finnegan; M E Hodson
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

Review 10.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.